US EditionQuva Adds a New, Forward Distribution Center to Its Industry Leading Integrated 503B and Data Services Platform
- On May 14, 2025, Quva Pharma announced a new forward distribution center in Sugar Land, Texas, its second dedicated facility.
- Quva has expanded its network of forward distribution centers for sterile injectable compounded drugs produced under its 503B outsourcing facility, enhancing capacity to support secure, efficient, and regulatory-compliant product distribution.
- The 20,000-square-foot Sugar Land facility complements the existing 40,000-square-foot Phoenix site and is near Quva's manufacturing operations.
- Stuart Hinchen, CEO of Quva, emphasized the company's commitment to enhancing trust and consistency within the pharmaceutical sector, addressing key challenges such as tariff impacts and DSCSA regulations.
- This facility increases Quva's capacity, supports its mission to improve medication delivery reliability, and will integrate with upcoming automated IV bag production.
Insights by Ground AI
Does this summary seem wrong?
11 Articles
11 Articles
All
Left
1
Center
4
Right
Quva Adds a New, Forward Distribution Center to Its Industry Leading Integrated 503B and Data Services Platform
The company's new Sugar Land, TX distribution facility is the second for Quva, as it expands its 503B forward distribution capabilities and adds another 20,000 sq. ft. of distribution capacity.
Coverage Details
Total News Sources11
Leaning Left1Leaning Right0Center4Last UpdatedBias Distribution80% Center
Bias Distribution
- 80% of the sources are Center
80% Center
L 20%
C 80%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
